Stocktoria
Stablecoin Development Corp SDEV
NYSE · stock · Pharmaceutical Preparations · website · IPO 2007-10-26
Stablecoin Development Corp financials (annual)
Bars are annual figures from 2017 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $9.8M | $5.9M | $10.5M | $14.4M | $10.2M | $9.9M | $6.6M | $12.5M | $18.2M |
| Gross profit | — | $6.5M | — | $6.1M | $7.8M | $6.5M | $6.0M | $4.9M | $11.0M | $15.4M |
| R&D expense | — | $42,000 | — | $34,000 | $174,000 | $44,000 | $285,000 | $184,000 | $259,000 | $410,000 |
| Operating income | -$8.4M | -$7.4M | — | -$4.1M | -$14.4M | -$8.9M | -$6.4M | -$9.4M | -$7.9M | -$7.3M |
| Income tax | $0 | $0 | — | $0 | $0 | $0 | $5,000 | $6,000 | $4,000 | $3,000 |
| Net income | -$22.1M | -$7.2M | — | -$9.6M | -$10.6M | -$5.8M | -$11.0M | -$9.7M | -$6.5M | -$7.4M |
| EPS (diluted) | — | — | — | — | — | — | $-0.31 | $-0.48 | $-0.46 | $-0.48 |
| Operating cash flow | -$8.4M | -$7.5M | — | -$4.3M | -$6.7M | -$9.2M | -$4.7M | -$7.9M | -$5.6M | -$6.3M |
| Free cash flow | — | -$7.5M | — | -$4.3M | -$6.8M | -$9.2M | -$4.7M | -$7.9M | -$5.6M | -$6.5M |
| Cash & equivalents | $8.0M | $430,000 | $751,000 | $2.9M | $5.4M | $7.5M | $12.0M | $6.9M | $3.2M | $3.2M |
| Inventory | — | $0 | $700,000 | $501,000 | $3.4M | $3.2M | $608,000 | $492,000 | $280,000 | $504,000 |
| Total assets | $9.0M | $3.4M | $3.9M | $9.0M | $16.4M | $24.0M | $15.2M | $11.2M | $9.4M | $10.1M |
| Total liabilities | $640.5M | $3.6M | $4.5M | $5.7M | $5.8M | $13.8M | $2.9M | $10.2M | $4.4M | $7.5M |
| Shareholders' equity | -$631.8M | -$129,000 | -$617,000 | $3.3M | $10.6M | $10.2M | $12.3M | $973,000 | $5.0M | $2.6M |
Growth · year-over-year · Revenue CAGR -7.5%
| Metric | FY2025 | FY2024 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | +66.5% | -43.8% | -27.4% | +41.2% | +2.7% | +50.5% | -47.2% | -31.4% | +53.2% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.